The past dean of Harvard Medical School, a global leader in sustainable investing and a Killam Award-winning geneticist will receive honorary degrees from Western at the 2013 convocations for the Schulich School of Medicine & Dentistry’s Doctor of Medicine (MD) program, the Richard Ivey School of Business’ Master of Business Administration (MBA) program and Western’s Hong Kong campus, respectively.
The ceremonies and honorees are scheduled for the following days:
Ian Ihnatowycz
Richard Ivey School of Business, MBA Convocation
Monday, April 8
Doctor of Laws, honoris causa (LL.D.)
Ian Ihnatowycz is president and CEO of First Generation Capital, a private investment holding company. Formerly president and CEO of Acuity Investment Management and Acuity Funds, Ihnatowycz founded Acuity in 1990 to provide discretionary asset management for pension, foundation and private clients as well as mutual and pooled funds. Acuity was the first Canadian advisor to the United Nations on the integration of environmental, social and governance factors within investment management. A committed philanthropist and supporter of educational, arts and community institutions, he and his wife, Marta Witer, provided the founding gift for the Ian O. Ihnatowycz Institute for Leadership at the Richard Ivey School of Business.
Dr. Joseph Martin
Schulich School of Medicine & Dentistry, MD Convocation
Friday, May 17
Doctor of Science, honoris causa (D.Sc.)
Dr. Joseph Martin is the Edward R. and Anne G. Lefler Professor of Neurobiology at the Harvard Faculty of Medicine and served as dean at Harvard Medical School from 1997-2007. Focused on achieving a better understanding of the causes of neurological and neurodegenerative disease, the former editor of Harrisons Principles of Internal Medicine established the National Institute of Health-sponsored Huntington Disease Center in 1980. Early work at the Center led to a breakthrough in identifying a genetic marker near the gene for Huntington’s disease, which culminated in the identification of the gene for the disorder.
Dr. Lap-Chee Tsui
Western Hong Kong Convocation
Sunday, May 26
Doctor of Science, honoris causa (D.Sc.)
Dr. Lap-Chee Tsui made what the Canadian Medical Hall of Fame described as the most significant breakthrough in human genetics in 50 years, namely the discovery of the cystic fibrosis gene. Currently serving as the 14th Vice-Chancellor of the University of Hong Kong, Dr. Tsui is the former Geneticist-in-Chief and Head of the Genetics and Genomic Biology Program of the Research Institute at The Hospital for Sick Children in Toronto. Tsui is a past recipient of the Killam Prize of the Canada Council, the Gairdner International Award, the Cresson Medal of Franklin Institute, and the Mead Johnson Award.